NASDAQ:TCBP TC Biopharm (TCBP) Stock Price, News & Analysis $1.70 +0.10 (+6.25%) (As of 10/28/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipShort InterestTrends About TC Biopharm Stock (NASDAQ:TCBP) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get TC Biopharm alerts:Sign Up Key Stats Today's Range$1.50▼$1.7550-Day Range$1.60▼$7.8552-Week Range$1.50▼$138.00Volume4.32 million shsAverage Volume363,771 shsMarket Capitalization$901,000.00P/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewTC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product under Phase 2/3 trails for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections as well as cancers. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.Read More… Tim Sykes’ Urgent Trade Alert: “Make this move now” (Ad)WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…Click here to see a unique election-year trade TC Biopharm Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks22nd Percentile Overall ScoreTCBP MarketRank™: TC Biopharm scored higher than 22% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for TC Biopharm.Read more about TC Biopharm's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Book Value per Share RatioTC Biopharm has a P/B Ratio of 0.05. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.11% of the outstanding shares of TC Biopharm have been sold short.Short Interest Ratio / Days to CoverTC Biopharm has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in TC Biopharm has recently decreased by 14.06%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldTC Biopharm does not currently pay a dividend.Dividend GrowthTC Biopharm does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted3.11% of the outstanding shares of TC Biopharm have been sold short.Short Interest Ratio / Days to CoverTC Biopharm has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in TC Biopharm has recently decreased by 14.06%, indicating that investor sentiment is improving significantly. News and Social Media1.8 / 5News Sentiment0.31 News SentimentTC Biopharm has a news sentiment score of 0.31. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.68 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for TC Biopharm this week, compared to 1 article on an average week.Search InterestOnly 2 people have searched for TCBP on MarketBeat in the last 30 days. This is a decrease of -78% compared to the previous 30 days.MarketBeat FollowsOnly 6 people have added TC Biopharm to their MarketBeat watchlist in the last 30 days. This is a decrease of -74% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, TC Biopharm insiders have not sold or bought any company stock.Percentage Held by Insiders15.44% of the stock of TC Biopharm is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 16.25% of the stock of TC Biopharm is held by institutions.Read more about TC Biopharm's insider trading history. Receive TCBP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TC Biopharm and its competitors with MarketBeat's FREE daily newsletter. Email Address TCBP Stock News HeadlinesTCBP Responds to False Social Media ClaimOctober 25, 2024 | prnewswire.comTC BioPharm (Holdings) plcOctober 24, 2024 | thestreet.comUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?October 29, 2024 | Behind the Markets (Ad)TC Biopharm enters research pact with Dr. Carlos Maluquer de MotesOctober 23, 2024 | markets.businessinsider.comBiotech Shares Rip Following Collaboration Announcement For Monkeypox ResearchOctober 22, 2024 | theglobeandmail.comTCBP Enters Research Planning Collaboration with Dr. Carlos Maluquer de Motes for Mpox TherapeuticOctober 22, 2024 | prnewswire.comTC Biopharm (Holdings) PLC – ADR trading resumesOctober 22, 2024 | markets.businessinsider.comTC Biopharm (Holdings) PLC – ADR trading halted, volatility trading pauseOctober 22, 2024 | markets.businessinsider.comSee More Headlines TCBP Stock Analysis - Frequently Asked Questions How have TCBP shares performed this year? TC Biopharm's stock was trading at $31.70 at the beginning of 2024. Since then, TCBP stock has decreased by 94.6% and is now trading at $1.70. View the best growth stocks for 2024 here. When did TC Biopharm's stock split? TC Biopharm's stock reverse split before market open on Monday, August 5th 2024. The 1-10 reverse split was announced on Monday, August 5th 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, August 5th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. When did TC Biopharm IPO? TC Biopharm (TCBP) raised $17 million in an initial public offering (IPO) on Friday, February 11th 2022. The company issued 4,100,000 shares at $4.25 per share. EF Hutton served as the underwriter for the IPO. How do I buy shares of TC Biopharm? Shares of TCBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of TC Biopharm own? Based on aggregate information from My MarketBeat watchlists, some other companies that TC Biopharm investors own include Johnson & Johnson (JNJ), Procter & Gamble (PG), Taiwan Semiconductor Manufacturing (TSM), Exxon Mobil (XOM), International Business Machines (IBM), NextEra Energy (NEE) and Union Pacific (UNP). Company Calendar Today10/28/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:TCBP CUSIPN/A CIK1872812 Webwww.tcbiopharm.com Phone44-14-1433-7557FaxN/AEmployees41Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio1.31 Current Ratio0.88 Quick Ratio0.88 Sales & Book Value Annual Sales$4.76 million Price / Sales0.19 Cash FlowN/A Price / Cash FlowN/A Book Value$32.47 per share Price / Book0.05Miscellaneous Outstanding Shares530,000Free Float446,000Market Cap$901,000.00 OptionableNot Optionable Beta0.10 2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (NASDAQ:TCBP) was last updated on 10/29/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredElon Musk Drops Stunning Bombshell?Elon Musk just dropped a BOMBSHELL that could send shockwaves throughout the tech industry… While deliverin...Paradigm Press | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TC Biopharm (Holdings) Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share TC Biopharm With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.